[DOI] [PMC free article] [PubMed] [Google Scholar] 82.Dore D.D., Seeger J.D., Chan K.A
Drink plenty of water : Dehydration reduces scalp elasticity and circulation
Highlights from Novo Nordisks presentation include (see Figure 1): Analysis of the three components in MACE: Semaglutide 2.4 mg reduced the risk of Non-fatal myocardial infarction by 28% Cardiovascular death by 15% (not statistically significant over the length of the trial) Non-fatal stroke by 7% (not statistically significant over the length of the trial) Analysis of confirmatory secondary endpoints: Semaglutide 2.4 mg reduced the risk of Composite heart failure events, comprising cardiovascular death, urgent heart failure visits and hospitalisations, by 18% Death from any cause by 19% Note: Since the result on cardiovascular death, the first confirmatory secondary endpoint, was not statistically significant over the length of the trial, the remaining secondary confirmatory endpoints were not tested for superiority due to hierarchical testing
What works for one person could prove ineffective for another, leading to unpredictable results and causing cause and disappointment
Peptides have swept the nation as the latest wellness trend, dominating conversations on social media and at dinner parties across the country
Also, liver enzymes such as aspartate transaminase and alanine transaminase had a significant decrease in the IF group (Tavakoli et al., 2025)
